Suchergebnisse - "André, Emmanuel"

PubPharm (7)

1

Programmatic management of rifampicin-resistant tuberculosis with standard regimen in Cameroon : a retrospective cohort study

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2022

von Jouego, C. | Gils, T. | Piubello, A. | +12

2

A sister lineage of the Mycobacterium tuberculosis complex discovered in the African Great Lakes region

enthalten in: Nature communications | 2020

von Ngabonziza, J. | Loiseau, C. | Marceau, M. | +22

3

Variable ability of rapid tests to detect Mycobacterium tuberculosis rpoB mutations conferring phenotypically occult rifampicin resistance

enthalten in: Scientific reports | 2019

von Torrea, G. | Ng, K. | Van Deun, A. | +14

4

Xpert Ultra Can Unambiguously Identify Specific Rifampin Resistance-Conferring Mutations

enthalten in: Journal of clinical microbiology | 2018

von Ng, K. | van Deun, A. | Meehan, C. | +6

5

Isoniazid-resistant tuberculosis treatment with first-line drugs

enthalten in: The Lancet. Infectious diseases | 2017

von Andre, E. | Martin, A.

CommentOn: Lancet Infect Dis. 2017 Feb;17 (2):223-234. - PMID 27865891

6

Diagnostic performance of smear microscopy and incremental yield of Xpert in detection of pulmonary tuberculosis in Rwanda

enthalten in: BMC infectious diseases | 2016

von Ngabonziza, J. | Ssengooba, W. | Mutua, F. | +8

7

Results from early programmatic implementation of Xpert MTB/RIF testing in nine countries

enthalten in: BMC infectious diseases | 2014

von Creswell, J. | Codlin, A. | Andre, E. | +11

1
[1]